We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Investigates Alpha-1-Antitrypsin for Severe COVID-19 Infection

News   Jun 30, 2020 | Original story from RCSI University of Medicine and Health Sciences

 
Clinical Trial Investigates Alpha-1-Antitrypsin for Severe COVID-19 Infection
 
 
Advertisement
 

RELATED ARTICLES

Drug for Inherited ALS Shows Promise in Early-stage Trial

News

A trial of an experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in an early-stage trial.

READ MORE

Food Poisoning Bacteria Causes Autoimmunity and May Be Linked to Alzheimer’s and Parkinson’s

News

Scientists have demonstrated that a Salmonella biofilm protein can cause autoimmune responses and arthritis in animals and postulate a link with neurodegenerative disease onset.

READ MORE

Broader Immune Repertoire for Neonates Exposed to Commensal Bacteria Antigens

News

Fresh evidence shows that early exposure to vaccine-, bacterial- or microbiota-derived antigens has a dramatic effect on the diversity of antibodies an adult mammal will have to fight future infections by pathogens.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE